hMG-HP

DRUG4 trials

Sponsors

Ferring Pharmaceuticals, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Conditions

Polycystic Ovary SyndromeSTERILITYSterility

Phase 4

Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.

TerminatedNCT02785822

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauPolycystic Ovary Syndrome

Start: 2017-02-23End: 2018-05-09Updated: 2019-02-25

Unknown Phase

Assessment of the Therapeutic Utility of hMG-HP

CompletedNCT01330784

Ferring PharmaceuticalsSterility

Start: 2006-10-31End: 2008-09-30Updated: 2011-04-07

Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation

CompletedNCT01331720

Ferring PharmaceuticalsSTERILITY

Start: 2007-11-30End: 2010-07-31Updated: 2011-04-08

Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist

CompletedNCT01331733

Ferring PharmaceuticalsSterility

Start: 2006-11-30End: 2009-03-31Updated: 2011-04-08